Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Pharm (Weinheim). 2012 Jun;345(6):444-53. doi: 10.1002/ardp.201100373. Epub 2012 Feb 3.

Design, synthesis, and biological evaluation of bromophenol derivatives as protein tyrosine phosphatase 1B inhibitors.

Author information

1
Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China.

Abstract

3-Bromo-4,5-bis(2,3-dibromo-4,5-dihydroxybenzyl)-1,2-benzenediol (BDB) is a bromophenol purified from the marine red alga Rhodomela confervoides and exhibits potent protein tyrosine phosphatase 1B (PTP1B) inhibition (IC(50)  = 1.7 µmol/L). In an effort to improve the PTP1B inhibitory activity, a series of derivatives were designed, synthesized, and evaluated in vitro. The preliminary structure-activity relationship indicated that the tricyclic scaffold and multi-bromine atoms (four to five) attached to the aryl rings are important for PTP1B inhibition. Among these, compound 26 exhibited remarkable inhibitory activity against PTP1B with an IC(50) of 0.89 µmol/L, which was approximately two-fold more potent than the initial lead compound BDB.

PMID:
22307562
DOI:
10.1002/ardp.201100373
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center